206 related articles for article (PubMed ID: 18235970)
21. Ten years of dengue drug discovery: progress and prospects.
Lim SP; Wang QY; Noble CG; Chen YL; Dong H; Zou B; Yokokawa F; Nilar S; Smith P; Beer D; Lescar J; Shi PY
Antiviral Res; 2013 Nov; 100(2):500-19. PubMed ID: 24076358
[TBL] [Abstract][Full Text] [Related]
22. True Blood: dengue virus evolution.
Wash R; Soria CD
Nat Rev Microbiol; 2015 Nov; 13(11):662. PubMed ID: 26439086
[TBL] [Abstract][Full Text] [Related]
23. Cissampelos pareira Linn: Natural Source of Potent Antiviral Activity against All Four Dengue Virus Serotypes.
Sood R; Raut R; Tyagi P; Pareek PK; Barman TK; Singhal S; Shirumalla RK; Kanoje V; Subbarayan R; Rajerethinam R; Sharma N; Kanaujia A; Shukla G; Gupta YK; Katiyar CK; Bhatnagar PK; Upadhyay DJ; Swaminathan S; Khanna N
PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004255. PubMed ID: 26709822
[TBL] [Abstract][Full Text] [Related]
24. The relevance of dengue virus genotypes surveillance at country level before vaccine approval.
Usme-Ciro JA; Méndez JA; Laiton KD; Páez A
Hum Vaccin Immunother; 2014; 10(9):2674-8. PubMed ID: 25483495
[TBL] [Abstract][Full Text] [Related]
25. Preclinical Antiviral Testing for Dengue Virus Infection in Mouse Models and Its Association with Clinical Studies.
Watanabe S; Low JG; Vasudevan SG
ACS Infect Dis; 2018 Jul; 4(7):1048-1057. PubMed ID: 29756760
[TBL] [Abstract][Full Text] [Related]
26. Discovery of Potent Non-nucleoside Inhibitors of Dengue Viral RNA-Dependent RNA Polymerase from Fragment Screening and Structure-Guided Design.
Lim SP; Noble CG; Nilar S; Shi PY; Yokokawa F
Adv Exp Med Biol; 2018; 1062():187-198. PubMed ID: 29845534
[TBL] [Abstract][Full Text] [Related]
27. Better late than never: antivirals for dengue.
Perry ST; Buck MD; Shresta S
Expert Rev Anti Infect Ther; 2011 Jul; 9(7):755-7. PubMed ID: 21810045
[No Abstract] [Full Text] [Related]
28. The medicinal chemistry of dengue fever.
Stevens AJ; Gahan ME; Mahalingam S; Keller PA
J Med Chem; 2009 Dec; 52(24):7911-26. PubMed ID: 19739651
[No Abstract] [Full Text] [Related]
29. Pharmacological intervention for dengue virus infection.
Lai JH; Lin YL; Hsieh SL
Biochem Pharmacol; 2017 Apr; 129():14-25. PubMed ID: 28104437
[TBL] [Abstract][Full Text] [Related]
30. Nucleobases and corresponding nucleosides display potent antiviral activities against dengue virus possibly through viral lethal mutagenesis.
Qiu L; Patterson SE; Bonnac LF; Geraghty RJ
PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006421. PubMed ID: 29672522
[TBL] [Abstract][Full Text] [Related]
31. Dengue fever: natural management.
Qadir MI; Abbas K; Tahir M; Irfan M; Raza Bukhari SF; Ahmed B; Hanif M; Rasul A; Ali M
Pak J Pharm Sci; 2015 Mar; 28(2):647-55. PubMed ID: 25730815
[TBL] [Abstract][Full Text] [Related]
32. Updates on Dengue Vaccine and Antiviral: Where Are We Heading?
Norshidah H; Vignesh R; Lai NS
Molecules; 2021 Nov; 26(22):. PubMed ID: 34833860
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of dengue antiviral candidates in vivo in mouse model.
Watanabe S; Vasudevan SG
Methods Mol Biol; 2014; 1138():391-400. PubMed ID: 24696350
[TBL] [Abstract][Full Text] [Related]
34. Dengue human infection models to advance dengue vaccine development.
Larsen CP; Whitehead SS; Durbin AP
Vaccine; 2015 Dec; 33(50):7075-82. PubMed ID: 26424605
[TBL] [Abstract][Full Text] [Related]
35. An Industry Perspective on Dengue Drug Discovery and Development.
Hernandez-Morales I; Van Loock M
Adv Exp Med Biol; 2018; 1062():333-353. PubMed ID: 29845543
[TBL] [Abstract][Full Text] [Related]
36. Towards antiviral therapies for treating dengue virus infections.
Kaptein SJ; Neyts J
Curr Opin Pharmacol; 2016 Oct; 30():1-7. PubMed ID: 27367615
[TBL] [Abstract][Full Text] [Related]
37. 3',5'Di-O-trityluridine inhibits in vitro flavivirus replication.
De Burghgraeve T; Selisko B; Kaptein S; Chatelain G; Leyssen P; Debing Y; Jacobs M; Van Aerschot A; Canard B; Neyts J
Antiviral Res; 2013 May; 98(2):242-7. PubMed ID: 23470860
[TBL] [Abstract][Full Text] [Related]
38. Dengue structural proteins as antiviral drug targets: Current status in the drug discovery & development.
S AH; Pujar GV; Sethu AK; Bhagyalalitha M; Singh M
Eur J Med Chem; 2021 Oct; 221():113527. PubMed ID: 34020338
[TBL] [Abstract][Full Text] [Related]
39. Tropical diseases. Hunt for dengue vaccine heats up as the disease burden grows.
Normile D
Science; 2007 Sep; 317(5844):1494-5. PubMed ID: 17872423
[No Abstract] [Full Text] [Related]
40. Identification of Potential Inhibitors for Targets Involved in Dengue Fever.
Shanmugam A; Ramakrishnan C; Velmurugan D; Gromiha MM
Curr Top Med Chem; 2020; 20(19):1742-1760. PubMed ID: 32552652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
